Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q4 Operating Loss Widens To SEK 11.9 Million

Feb 20 (Reuters) - KANCERA AB  KANC.ST : 
    * Q4 OPERATING LOSS SEK 11.9 MILLION VERSUS LOSS SEK 6.5 
MILLION 
YEAR AGO 
 
Source text for Eikon:  ID:nWkr3j8X4w  
Further company coverage:  KANC.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on Novakand Pharma AB

See all news